Centene Corporation

Filing receipts

“Gross margin increased $186 million in the three months ended March 31, 2026, compared to the corresponding period in 2025 primarily driven by rate and revenue increases and continued tangible progress in managing medical costs.”

“Interest expense (164) (170) 4 % Earnings before income tax 2,099 1,746 20 % Income tax expense 560 432 30 % Net earnings 1,539 1,314 17 % (Earnings) loss attributable to noncontrolling interests 2 (3) 167 % Net earnings attributable to Centene Corporation $ 1,541 $ 1,311 18 % Diluted earnings per common share attributable to Centene Corporation $ 3.11 $ 2.63 18 % n.m.: not meaningful 25 Table of Contents Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025 Total Revenues Total revenues increased 7% in the three months ended March 31, 2026, over the corresponding period in 2025, primarily driven by premium yield and membership growth in the PDP business, state-dir...”

“Gross margin increased $350 million in the three months ended March 31, 2026, compared to the corresponding period in 2025 primarily driven by rate increases and an increase to the PDR for our Medicare Advantage business in 2025 versus no PDR in 2026 as a result of our progression towards profitability, partially offset by medical and pharmacy costs.”